3-O-alpha-L-fucopyranosyl-(1→2)-beta-D-arabinopyranosyl-(1→3)-beta-D-glucopyranosyl-((1→3)-beta-D- arabinopyranosyljujubogenin - Compound Card

3-O-alpha-L-fucopyranosyl-(1→2)-beta-D-arabinopyranosyl-(1→3)-beta-D-glucopyranosyl-((1→3)-beta-D- arabinopyranosyljujubogenin

Select a section from the left sidebar

3-O-alpha-L-fucopyranosyl-(1→2)-beta-D-arabinopyranosyl-(1→3)-beta-D-glucopyranosyl-((1→3)-beta-D- arabinopyranosyljujubogenin

Structure
Zoomed Structure
  • Family: Plantae - Rhamnaceae
  • Kingdom: Plantae
  • Class: Saponin
    • Subclass: Saponin Glycoside
Canonical Smiles OCC1OC(OC2C(O)COC(C2OC2OC(C)C(C(C2O)O)O)O[C@@H]2CC[C@]3(C(C2(C)C)CC[C@@]2(C3CCC3[C@@]42CO[C@]2(C4)C3[C@@](C)(O)C[C@@H](O2)C=C(C)C)C)C)C(C(C1O)OC1OCC(C(C1O)O)O)O
InChI InChI=1S/C52H84O21/c1-22(2)15-24-16-50(8,63)42-25-9-10-30-48(6)13-12-31(47(4,5)29(48)11-14-49(30,7)51(25)20-52(42,73-24)66-21-51)69-46-41(72-44-37(61)35(59)32(56)23(3)67-44)39(27(55)19-65-46)70-45-38(62)40(34(58)28(17-53)68-45)71-43-36(60)33(57)26(54)18-64-43/h15,23-46,53-63H,9-14,16-21H2,1-8H3/t23?,24-,25?,26?,27?,28?,29?,30?,31+,32?,33?,34?,35?,36?,37?,38?,39?,40?,41?,42?,43?,44?,45?,46?,48-,49+,50-,51-,52-/m0/s1
InChIKey BDIYDYFANYZMCA-HSRJDBDOSA-N
Formula C52H84O21
HBA 21
HBD 11
MW 1045.22
Rotatable Bonds 10
TPSA 314.83
LogP -0.54
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 73
Formal Charge 0
Fraction CSP3 0.96
Exact Mass 1044.55
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Ziziphus spina-christi Rhamnaceae Plantae 264981
2 Zizyphus spina-christi Rhamnaceae Plantae 264981

Showing of synonyms

  • el-Din Hussein Mahran G, Glombitza K.W, et al. (1996). Novel Saponins from Zizyphus spina-christi Growing in Egypt. Planta medica, 1996, 62(2), 163-5. [View] [PubMed]
  • Mahran G, Glombitza K, et al. (1993). Saponins of Zizyphus spina-christi Growing in Egypt. Planta Medica, 1993, 59(S 1), A612-A613. [View]

No compound-protein relationship available.

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCC(C6)OC7OCCC(C7OC8CCCCO8)OC(OCC9)CC9OC1CCCCO1

Level: 4

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCC(C6)OC7OCCC(OC8CCCCO8)C7OC9CCCCO9

Level: 3

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCC(C6)OC(OCC7)CC7OC(OCC8)CC8OC9CCCCO9

Level: 3

Mol. Weight: 1045.22 g/mol

Structure

SMILES: O1CCCCC1OC(COCC2)C2OC(OCC3)CC3OC4CCCCO4

Level: 3

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCC(C6)OC(OCCC7)C7OC8CCCCO8

Level: 2

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCC(C6)OC(OCC7)CC7OC8CCCCO8

Level: 2

Mol. Weight: 1045.22 g/mol

Structure

SMILES: O1CCCCC1OC2CC(OCC2)OC3CCOCC3

Level: 2

Mol. Weight: 1045.22 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCC(C6)OC7CCCCO7

Level: 1

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOC(C2)(OC3)C1C(C234)CCC5C4CCC6C5CCCC6

Level: 0

Mol. Weight: 1045.22 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1045.22 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.46
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
146686.86
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
19171121.3

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.68
Plasma Protein Binding
28.08
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.33
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-445871.91
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.39
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-34794659067.79
Rat (Acute)
4.0
Rat (Chronic Oral)
75.07
Fathead Minnow
43920843.24
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
3913430649.2
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-2164.46
Log(P)
2.13
Log S
-2.65
Log(Vapor Pressure)
-128867201.63
Melting Point
221.92
pKa Acid
-938908.06
pKa Basic
-7534.84
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Ferrochelatase, mitochondrial P22830 HEMH_HUMAN Homo sapiens 3 0.7249

Download SDF